×

CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS

  • US 20130164787A1
  • Filed: 02/06/2013
  • Published: 06/27/2013
  • Est. Priority Date: 04/22/2009
  • Status: Active Grant
First Claim
Patent Images

1. An in vitro human pancreatic endoderm cell population comprising differentiated cells derived from dedifferentiated genetically reprogrammed cells and an ERBB receptor tyrosine kinase activating agent.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×